Form 4 for MRK Merck & Co.
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0001127602-23-014206 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-03 | 2023-05-01 | MRK | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $115.47 | +643 | 4,376 | +17% | +$74.2K |
| D | 2023-05-03 | 2023-05-01 | MRK | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | F - Tax | $115.47 | -221 | 4,155 | -5% | -$25.5K |
| D | 2023-05-03 | 2023-05-01 | MRK | LeCointe-Cephas Lisa | SVP Chief Ethics, Com Off | M - OptEx | $0.00 | -643 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | M | A | 643 | $115.47 | 4,375.69 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-01 | F | D | 221 | $115.47 | 4,154.69 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 3 | Derivative | Restricted Stock Unit | 2023-05-01 | M | D | 643 | $0.00 | 0 | D | — · 2021-05-01 to 2023-05-01 | 643 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/1/2021, 5/1/2022 and 5/1/2023. |